Timeline of Biotech IPO Filings in Hong Kong 

Filing Date

05/07/2018  - Ascletis Pharma

Focus: Antivirals for HCV, HIV and HBV

HK: 1672

06/06/2018  - Hua Medicine

Focus: Type 2 Diabetes

HK: 2552

Focus: Antibiotics for superbug infections

06/28/2018  - Innovent Biologics

Focus: Various

HK: 1801

07/03/2018  - AOBiome Therapeutics

Focus: Ammonia-oxidizing bacteria

07/17/2018  - CanSino Biologics

Focus: Vaccines

HK: 6185

07/23/2018  - Viva Biotech Holdings

Focus: CRO

HK: 1873

07/27/2018  - BeiGene

Focus: Oncology

HK: 6160

Focus: Oncology, various others

08/20/2018  - Ascentage Pharma

Focus: Oncology, hep B, AMD

08/22/2018  - Mabpharm

Focus: Oncology, autoimmune diseases

Focus: Oncology, CNS, diabetes

HK: 3692

HK: 2359

09/18/2018  - WuXi AppTec

Focus: CRO

Focus: Vaccines

11/13/2018  - CStone Pharmaceuticals

Focus: Oncology

HK: 2616

Focus: Biologics

HK: 2696

03/11/2019  - Frontage Holdings

Focus: CRO

HK: 1521

Focus: Oncology

Focus: Fibrosis

04/29/2019  - TOT BIOPHARM

Focus: Oncology

06/24/2019  - Tasly Biopharma

Focus: Multiple

07/08/2019  - SinoMab BioScience

Focus: Immunology

07/15/2019  - Alphamab Oncology

Focus: Oncology

08/26/2019  - Pharmaron Beijing

Focus: CRO

09/02/2019  - Immunotech Biopharm

Focus: Cellular Immunotherapy

10/17/2019  - InnoCare Pharma

Focus: Oncology

HK: 1877

HK: 2181

HK: 6855